Sabra R. Purtill
Sabra R. Purtill's purchase track record
Sabra R. Purtill has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/31/2025 | VRSK | $98K | -0.4% | -16.8% | +5.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
SiriusPoint (SPNT) Valuation Questioned After Recent Price Rise. Recent market discussion has focused on whether SiriusPoint remains undervalued following a recent increase in its share price. The company currently trades with a low trailing P/E ratio of 5.7, which is significantly below the average analyst target of $28.75. This valuation gap has prompted investors to reassess the stock's position within its 52-week range of $17.39 to $26.50.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
AIG analysts lower price targets while highlighting dividend appeal. Recent analyst reports from Wells Fargo and Keefe, Bruyette & Woods kept their coverage on AIG but reduced price targets to $83 and $90 respectively. At the same time, commentary highlighted AIG’s dividend yield of about 2.2% as attractive for income‑focused investors. A separate analysis noted the insurer’s exposure to rising war‑risk premiums and compared its Q2 performance favorably against other multi‑line insurers.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Corebridge Financial to Report Q3 2026 Results. Corebridge Financial has announced the schedule for its third-quarter 2026 financial results. Separately, industry news indicates that BHF's Shield Annuities are maintaining strong sales growth. The stock currently trades with a dividend yield of 4.43% and an average analyst target of $38.83.
Transaction History
| VRSK | ▲ Buy | Grant | 194 | $0 | 9/30/2026 | View on chart |
| VRSK | ▲ Buy | Grant | 163 | $0 | 6/30/2026 | View on chart |
| SPNT | ▲ Buy | Grant | 5,903 | $137K | 5/29/2026 | View on chart |
| VRSK | ▲ Buy | Grant | 1,347 | $0 | 5/19/2026 | View on chart |
| VRSK | ▲ Buy | Grant | 138 | $0 | 3/31/2026 | View on chart |
| VRSK | ▲ Buy | Grant | 117 | $0 | 12/31/2025 | View on chart |
| VRSK | ▲ Buy | Open Market | 450 | $98K | 10/31/2025 | View on chart |
| VRSK | ▲ Buy | Grant | 104 | $0 | 9/30/2025 | View on chart |
| VRSK | ▲ Buy | Grant | 38 | $0 | 6/30/2025 | View on chart |
| VRSK | ▲ Buy | Grant | 735 | $0 | 5/20/2025 | View on chart |
| AIG | ▲ Buy | Option Exercise | 7,552 | $0 | 6/19/2024 | View on chart |
| AIG | ▼ Sell | Tax Withholding | 3,856 | $289K | 6/19/2024 | View on chart |
| CRBG | ▼ Sell | Tax Withholding | 9,427 | $231K | 3/4/2024 | View on chart |
| AIG | ▼ Sell | Tax Withholding | 1,656 | $119K | 2/27/2024 | View on chart |
| AIG | ▲ Buy | Option Exercise | 3,243 | $0 | 2/21/2024 | View on chart |
| AIG | ▲ Buy | Grant | 10,376 | $0 | 2/20/2024 | View on chart |
| CRBG | ▼ Sell | Tax Withholding | 26,468 | $640K | 1/17/2024 | View on chart |
| CRBG | ▼ Sell | Tax Withholding | 9,427 | $191K | 3/1/2023 | View on chart |
| CRBG | ▼ Sell | Tax Withholding | 20,113 | $430K | 1/31/2023 | View on chart |
| CRBG | ▲ Buy | Grant | 171,611 | $0 | 9/14/2022 | View on chart |
| AIG | ▼ Sell | Tax Withholding | 2,175 | $126K | 3/1/2022 | View on chart |
| AIG | ▲ Buy | Option Exercise | 4,259 | $0 | 2/22/2022 | View on chart |
| AIG | ▼ Sell | Tax Withholding | 499 | $31K | 1/14/2022 | View on chart |
| AIG | ▼ Sell | Tax Withholding | 1,747 | $108K | 1/14/2022 | View on chart |
| AIG | ▲ Buy | Option Exercise | 1,383 | $0 | 1/1/2022 | View on chart |
| AIG | ▲ Buy | Option Exercise | 4,744 | $0 | 1/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Verisk price targets trimmed as analysts weigh AI impact
BMO Capital and Morgan Stanley recently lowered their price targets for Verisk Analytics to $217 and $215, respectively, while maintaining positive ratings. This adjustment reflects ongoing debate among analysts regarding the company's growth outlook and the potential impact of artificial intelligence on its business model. The stock is currently trading near the upper end of its 52-week range, with an average analyst target of $227.94.
Verisk price targets trimmed as analysts weigh AI impact. BMO Capital and Morgan Stanley recently lowered their price targets for Verisk Analytics to $217 and $215, respectively, while maintaining positive ratings. This adjustment reflects ongoing debate among analysts regarding the company's growth outlook and the potential impact of artificial intelligence on its business model. The stock is currently trading near the upper end of its 52-week range, with an average analyst target of $227.94.